India's Pharmaceutical Exports

Country Profile

DR Congo

DR Congo is a growing market for Indian pharmaceuticals — $236M in FY 2025–26. Medicines accounts for 52% of shipments, with vaccines contributing $96.1M. The compound annual growth rate since FY2022 stands at 10.4%.

🇨🇩 $236M · 1.5× growth since FY2022 · 10.4% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$236M
Exports FY2025–26 DGCIS
1.5×
Growth FY2022→2026
10.4%
CAGR FY2022→2026
52%
Medicines Share
5
Product Categories Supplied
DR Congo is a growing market for Indian pharmaceuticals — $236M in FY 2025–26. Medicines accounts for 52% of shipments, with vaccines contributing $96.1M. The compound annual growth rate since FY2022 stands at 10.4%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $124M (52.4%) Vaccines $96.1M (40.6%) Medicine Ingredients $13.3M (5.6%) Surgical & Hospital Supplies $1.87M (0.8%) Traditional & Herbal $1.21M (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to DR Congo in the RBI overseas direct investment dataset (2011–2026).